<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131-pharmaceuticals-12-00157">
 <label>131.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>E.M.</given-names>
   </name>
   <name>
    <surname>Shiryaev</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>Y.-S.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Tharappel</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: Inhibiting viral replication and decreasing viral entry</article-title>
  <source>Cell Discov.</source>
  <year>2018</year>
  <volume>4</volume>
  <pub-id pub-id-type="doi">10.1038/s41421-018-0034-1</pub-id>
  <?supplied-pmid 29872540?>
  <pub-id pub-id-type="pmid">29872540</pub-id>
 </element-citation>
</ref>
